NAV
$79.75
AUM
$3.0B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.62
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.26% | +8.48% | +13.30% | +25.09% | +9.91% | +5.75% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 13.99% |
| 2 | JNJ | Johnson & Johnson | 8.55% |
| 3 | ABBV | AbbVie Inc | 6.06% |
| 4 | UNH | UnitedHealth Group Inc | 5.43% |
| 5 | MRK | Merck & Co Inc | 4.64% |
| 6 | TMO | Thermo Fisher Scientific Inc | 2.92% |
| 7 | AMGN | Amgen Inc | 2.86% |
| 8 | GILD | Gilead Sciences Inc | 2.63% |
| 9 | ISRG | Intuitive Surgical Inc | 2.37% |
| 10 | PFE | Pfizer Inc | 2.35% |
The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
Inception Date: 2013-10-21